Tiny trial of infant blood pressure cuff ends early
NCT ID NCT05976425
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new blood pressure device called ModPG3 on 7 newborns and infants to see if it meets international accuracy standards. The device uses two methods to measure blood pressure during cuff inflation and deflation. The trial was terminated early, so results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ModPG3 blood pressure device
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
East Carolina University
Greenville, North Carolina, 27834, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal implant may tackle pain and blood pressure together
- Wrist-Worn blood pressure monitor put to the test against gold standard
- AI and a pulse oximeter may predict dangerous blood pressure swings in spinal cord injury
- Could a simple cuff replace needles for blood pressure monitoring?
- Daily vitamin pills may sharpen teen minds and strengthen bones, large trial tests
- Brain-Safe bypass: smart monitor aims to personalize blood pressure during heart surgery